EC Number   |
Inhibitors |
Structure |
|---|
    2.7.1.32 | (1-azabicyclo[2.2.2]octan-3-yl)bis(5-chlorothiophen-2-yl)methanol |
- |
   |
| 2.7.1.32 | (1-azabicyclo[2.2.2]octan-3-yl)bis(5-chlorothiophen-2-yl)methanol |
precursor of (1S)-1-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-3-[2-[(oxan-4-yl)oxy]phenyl]-1-phenylpropan-1-ol, inhibits competitively against ATP, but not against choline |
|
| 2.7.1.32 | (1S)-1-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-3-[2-[(oxan-4-yl)oxy]phenyl]-1-phenylpropan-1-ol |
- |
|
| 2.7.1.32 | (1S)-1-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-3-[2-[(oxan-4-yl)oxy]phenyl]-1-phenylpropan-1-ol |
a structure-directed, selective ChoKalpha inhibitor. Treatment of HeLa cells and other cancer cells with the compound leads to a substantial reduction in the pCho level, and causes a reversible growth arrest but not cell death |
|
| 2.7.1.32 | (4-methyl-1,4-diazepan-1-yl)(4'-((4-methyl-1,4-diazepan-1-yl)-methyl)-[1,1'-biphenyl]-4-yl)methanone |
- |
|
| 2.7.1.32 | (azepan-1-yl)(piperazin-1-yl)methanone |
- |
|
| 2.7.1.32 | 1,1',1''-(benzene-1,3,5-triylmethylene)tris[(4-dimethylamino)pyridinium] tribromide |
- |
|
| 2.7.1.32 | 1,1',1''-(benzene-1,3,5-triylmethylene)tris[4-(3,5-dichloro-N-methylanilino)pyridinium] tribromide |
- |
|
| 2.7.1.32 | 1,1',1''-(benzene-1,3,5-triylmethylene)tris[4-(4-chloro-N-methylanilino)pyridinium] tribromide |
- |
|
| 2.7.1.32 | 1,1',1''-(benzene-1,3,5-triylmethylene)tris[4-(N-methylanilino)pyridinium] tribromide |
- |
|
